Skip to main content
Livermore
Livermore
ZHEN

First Manhattan Co

SEC CIK
0000728083
Latest filing
Aug 14, 2026

GSK holding history

GSK plc in every 13F filed by First Manhattan Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
3,941
Value
$208.4K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of GSK by First Manhattan Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,941$208.4K<0.1%00.0%UnchangedHolders
Q1 20263,941$219.4K<0.1%−1,012−20.4%ReducedHolders
Q4 20254,953$244.9K<0.1%+274+5.9%AddedHolders
Q3 20254,679$204.0K<0.1%+4,679NewHolders
Q2 20250$00.0%−6,019−100.0%Sold outHolders
Q1 20256,019$235.6K<0.1%−3,028−33.5%ReducedHolders
Q4 20249,047$309.4K<0.1%00.0%UnchangedHolders
Q3 20249,047$373.4K<0.1%−492−5.2%ReducedHolders
Q2 20249,539$369.7K<0.1%+2,743+40.4%AddedHolders
Q1 20246,796$291.4K<0.1%+480+7.6%AddedHolders
Q4 20236,316$234.1K<0.1%−946−13.0%ReducedHolders
Q3 20237,262$263.2K<0.1%−4,071−35.9%ReducedHolders
Q2 202311,333$403.9K<0.1%00.0%UnchangedHolders
Q1 202311,333$403.2K<0.1%−729−6.0%ReducedHolders
Q4 202212,062$423.9K<0.1%−1,714−12.4%ReducedHolders
Q3 202213,776$405.0K<0.1%−6,049−30.5%ReducedHolders
Q2 202219,825$862.0K<0.1%00.0%UnchangedHolders
Q1 202219,825$863.0K<0.1%−45−0.2%ReducedHolders
Q4 202119,870$876.0K<0.1%+2,600+15.1%AddedHolders
Q3 202117,270$659.0K<0.1%−680−3.8%ReducedHolders
Q2 202117,950$714.0K<0.1%−701−3.8%ReducedHolders
Q1 202118,651$665.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.